We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood

By LabMedica International staff writers
Posted on 14 Apr 2023

Every year, over one million people succumb to hepatitis B or hepatitis C, while 650,000 die from HIV-related causes and 1. More...

5 million contract HIV. The World Health Organization aims to eliminate all three viruses by 2030, requiring new testing methods to decrease case numbers. The most common test for hepatitis B, hepatitis C, and HIV involves drawing blood from a vein with a needle. However, this approach is not always suitable in prisons, drug rehabilitation centers, and homeless shelters or in countries where blood sample shipping and refrigerated storage pose challenges. Alternative methods, such as dried blood spot tests, can detect nucleic acid from the three viruses in a single blood spot.

At this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (April 15–18), researchers at Copenhagen University Hospital (Copenhagen, Denmark) presented data on a test capable of detecting HIV, hepatitis B, and hepatitis C using a single drop of blood. The test involves pricking the individual's finger, collecting a few blood spots on filter paper, and allowing them to dry. The Hologic Panther System, commonly found in public health laboratories, then employs transcription mediated amplification to analyze one blood spot for genetic material from the three viruses.

The researchers assessed the test by analyzing 20 samples containing known amounts of HIV, hepatitis B, and hepatitis C using the dried blood spot method (60 samples in total) and successfully detected the viruses in all samples. Plasma dilution determined the lower detection limit, revealing the capability to detect the viruses at levels significantly lower than those typically found in untreated patients.

“We've shown that using existing hospital equipment, it is possible to detect HIV, hepatitis B and hepatitis C from a single drop of blood,” said Stephen Nilsson-Møller at the Department of Clinical Microbiology, Copenhagen University Hospital. “The dried blood spot test is ideal for places where you don't want to use a needle for safety reasons or where it is less practical. It is also suitable for developing countries or places where you run the risk of a blood sample being ruined before it is transferred to a laboratory that can analyze it. Blood samples need to be analyzed within six hours when kept at room temperature, while dried blood spots can last for nine months without refrigeration.”

Related Links:
Copenhagen University Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.